Control of Stromal Keratitis by Inhibition of Neovascularization
- 30 September 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (3) , 1021-1029
- https://doi.org/10.1016/s0002-9440(10)61777-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Endothelial Monocyte Activating Polypeptide II Induces Endothelial Cell Apoptosis and May Inhibit Tumor AngiogenesisMicrovascular Research, 2000
- TUMOUR NECROSIS FACTOR RECEPTOR I (p55) IS UPREGULATED ON ENDOTHELIAL CELLS BY EXPOSURE TO THE TUMOUR-DERIVED CYTOKINE ENDOTHELIAL MONOCYTE- ACTIVATING POLYPEPTIDE II (EMAP-II)Cytokine, 2000
- Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryoDevelopmental Dynamics, 2000
- A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesThe EMBO Journal, 1999
- Herpes Simplex Virus Replication-Induced Expression of Chemokines and Proinflammatory Cytokines in the Eye: Implications in Herpetic Stromal KeratitisJournal of Interferon & Cytokine Research, 1998
- Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoimmune Disease After Viral InfectionScience, 1998
- Immunopathogenesis of herpetic ocular diseaseImmunologic Research, 1997
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973